Clinical Trials
Parexel and NeoGenomics announce partnership to improve clinical trials
Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization, and NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services and global oncology contract research...
News
G-CON PODs Successfully Delivered for Cell Therapy Manufacturing on an Accelerated Timeline
G-CON Manufacturing, the leader in prefabricated, flexible cleanroom solutions, has successfully delivered and installed 3 PODs to a clinical-stage immuno-oncology company for cell therapy manufacturing. With the assistance of G-CON Building Services, a subsidiary of G-CON Manufacturing, Inc. that...
News
Vetter continues its successful performance at the 2021 CMO Leadership Awards
Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), was granted the 2021 CMO Leadership Awards in five core categories – quality, expertise, compatibility, capabilities, and service. The award, now in its tenth year, was given by the...
News
Peli BioThermal Launches new Webinar Series
Peli BioThermal, the global name in temperature controlled packaging, partners with industry experts to offer InnovationShare, a new webinar series focusing on best practices in clinical and commercial supply chain management. InnovationShare debuts in early March with monthly courses...
News
President of The Pistoia Alliance: “Let’s not wait another 100 years to collaborate”
Dr Steve Arlington, President of The Pistoia Alliance, a global not-for-profit advocating for greater collaboration in biopharma, has called on the life science industry to learn the lessons of the COVID-19 pandemic and seek out more opportunities to collaborate.
COVID-19...
News
QS-21, the Gold Standard of immune system activators used in Covid-19 and other vaccines to be presented by CEO Gaston Salinas at BIO CEO...
A novel approach for ensuring the virtually unlimited production of QS-21, the ‘Gold Standard’ adjuvant for improving vaccine efficacy, will be the subject of an upcoming presentation at the BIO CEO & Investor Digital Conference, starting February 16.
Gaston Salinas,...
News
Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South Korea
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, and SK Bioscience, a vaccine business subsidiary of SK Group, announced an expanded collaboration and license agreement. In addition to the already existing manufacturing arrangement, SK Bioscience...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















